BioStem Technologies, Inc. BSEM
1.13 USD +0.09 (+8.65%)
At closeNov 6, 2026, 4:09 PM EST
1.12 -0.01 -0.88%
After hours · Nov 6, 4:09 PM ET
1.01 Day range 1.15
1.04 52-week range 8.20
- YTD
- -70.34%
- 1 year
- -70.80%
- Market cap
- 21.10M
- EPS (ttm)
- 0.88
- P/E ratio
- 1.28
- YTD return
- -70.34%
- 1-year return
- -70.80%
- Volume
- 100.82K
- Avg volume
- 160.56K
- Open
- 1.03
- Previous close
- 1.04
- Day's range
- 1.01 – 1.15
- 52-week range
- 1.04 – 8.20
- Earnings date
- Aug 12, 2024
5D -0.10 (-8.13%)
Next earnings
Aug 12, 2024
Expected Aug 12, 2024. Consensus EPS estimate 0.12.
Financials — quick view
BSEM Revenue — quarterly 7.90M
BSEM Net income — quarterly -8.97M
BSEM EPS — quarterly -0.52
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | 0.31 | 0.32 | +0.01 | +3.23% |
| Aug 12, 2024 | Jun 1, 2024 | 0.12 | — | — | — |
| Aug 12, 2024 | Jun 1, 2024 | 0.12 | 0.30 | +0.18 | +150.00% |
| May 14, 2024 | Mar 1, 2024 | 0.74 | — | — | — |
| May 14, 2024 | Mar 1, 2024 | 0.74 | 0.20 | -0.54 | -72.97% |
| Apr 1, 2024 | Dec 1, 2023 | 0.47 | — | — | — |
News
Why Cloudflare Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket 
BioStem Secures US Patent, Additional US And Mexico Allowances For Tissue Technologies 
12 Health Care Stocks Moving In Friday's Intraday Session 
12 Health Care Stocks Moving In Thursday's Intraday Session 
BioStem Technologies Q2 EPS $(0.52), Sales $7.899M Down From $10.963M YoY 
BioStem Technologies Announces It Received Nasdaq Approval For The Company’s Common Stock For Listing On The Nasdaq Capital Market; Co. To Begin Trading On Nasdaq On August 7, 2026 Under The Ticker Symbol "BSEM" 
Biostem Technologies Files Form 10 Share Registration Statement With The SEC; Reaffirms Planned Nasdaq Listing - NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova Allograft
- EXCLUSIVE: BioStem Technologies Reports Q1 Net Revenue Up 211% YoY
Your note
Sign in to keep a note on BSEM — it syncs with the Stock Master app.